Autoantibodies against the chemokine receptor 3 predict cardiovascular risk.Felix S Müller,Zouhair Aherrahrou,Hanna Grasshoff,Marc W Heidorn,Jens Y Humrich,Laurence Johanson,Redouane Aherrahrou,Tobias Reinberger,Andreas Schulz,Vincent Ten Cate,Alejandro Pallares Robles,Thomas Koeck,Steffen Rapp,Tanja Lange,Lukas Brachaczek,Finn Luebber,Jeanette Erdmann,Harald Heidecke,Kai Schulze-Forster,Ralf Dechend,Karl J Lackner,Norbert Pfeiffer,Jasmin Ghaemi Kerahrodi,Oliver Tüscher,Andreas Schwarting,Konstantin Strauch,Thomas Münzel,Jürgen H Prochaska,Gabriela Riemekasten,Philipp S WildEuropean heart journal(2023)引用 0|浏览10暂无评分摘要In individuals free of autoimmune disease, anti-CXCR3 aAbs were abundant, related to CV end-organ damage, and predicted all-cause death as well as cardiac morbidity and mortality in conjunction with the acceleration of experimental atherosclerosis.更多查看译文AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要